Michael D Roth

Title(s)Professor, Medicine
SchoolMedicine
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Marijuana smoke promotes dysfunctional macrophage responses to HIV and pneumonia
    NIH R01DA037102May 15, 2014 - Dec 31, 2020
    Role: Principal Investigator
    CYTOKINES AS PREDICTORS OF DISEASE PROGRESSION IN SCLERODERMA LUNG DISEASE
    NIH R01AR055075Sep 19, 2006 - Aug 31, 2012
    Role: Principal Investigator
    Vector-based Generation of Monoclonal Antibodies against the CB2 Receptor
    NIH R21DA021813Sep 1, 2006 - Jun 30, 2010
    Role: Principal Investigator
    Adjuvant immunotherapy for non-small cell lung cancer
    NIH R21CA110494Aug 16, 2004 - Jul 31, 2007
    Role: Principal Investigator
    CLINICAL CENTERS FOR FEASIBILITY STUDIES ON RETINOID TRE
    NIH/NHLBI N01HR096143Oct 12, 1999 - Sep 29, 2002
    Role: Principal Investigator
    Cocaine Smoking Effects on Lung Immunity &Host Defense
    NIH R01DA008254Jun 1, 1993 - Aug 31, 2007
    Role: Principal Investigator
    CYTOTOXIC CELL REGULATION BY THE PULMONARY MACROPHAGE
    NIH K08CA001549Sep 30, 1990 - Sep 29, 1993
    Role: Principal Investigator
    Pulmonary and Immunologic Effects of Marijuana Use on HIV and Viral Immunity
    NIH R01DA003018Jul 1, 1982 - Apr 30, 2012
    Role: Principal Investigator
    PULMONARY EFFECTS OF HABITUAL USE OF MARIJUANA
    NIH R37DA003018Jul 1, 1982 - Sep 29, 2006
    Role: Co-Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. High 68 Ga-FAPI-46 uptake in a pulmonary necrotizing granuloma in a patient with subcutaneous lipoma. Eur J Nucl Med Mol Imaging. 2021 Sep 21. Hotta M, Benz MR, Allen-Auerbach MS, Crompton JG, Roth MD, Eilber FC, Calais J. PMID: 34546387.
      View in: PubMed   Mentions:    Fields:    
    2. SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: How to incorporate two Food and Drug Administration-approved therapies in clinical practice. Arthritis Rheumatol. 2021 Jul 27. Khanna D, Lescoat A, Roofeh D, Bernstein EJ, Kazerooni EA, Roth MD, Martinez F, Flaherty KR, Denton CP. PMID: 34313399.
      View in: PubMed   Mentions: 1     Fields:    
    3. Predictive Significance of Serum Interferon-Inducible Protein Score for Response to Treatment in Systemic Sclerosis-Related Interstitial Lung Disease. Arthritis Rheumatol. 2021 06; 73(6):1005-1013. Assassi S, Li N, Volkmann ER, Mayes MD, Rünger D, Ying J, Roth MD, Hinchcliff M, Khanna D, Frech T, Clements PJ, Furst DE, Goldin J, Bernstein EJ, Castelino FV, Domsic RT, Gordon JK, Hant FN, Shah AA, Shanmugam VK, Steen VD, Elashoff RM, Tashkin DP. PMID: 33350170.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    4. The MUC5B promoter variant does not predict progression of interstitial lung disease in systemic sclerosis. Semin Arthritis Rheum. 2020 10; 50(5):963-967. Volkmann ER, Tashkin DP, Roth MD, Li N, Charles J, Mayes M, Kim G, Goldin J, Pourzand L, Clements PJ, Furst DE, Khanna D, Elashoff RM, Assassi S. PMID: 32906032.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    5. Treatment With Mycophenolate and Cyclophosphamide Leads to Clinically Meaningful Improvements in Patient-Reported Outcomes in Scleroderma Lung Disease: Results of Scleroderma Lung Study II. ACR Open Rheumatol. 2020 Jun; 2(6):362-370. Volkmann ER, Tashkin DP, LeClair H, Roth MD, Kim G, Goldin J, Clements PJ, Furst DE, Khanna D. PMID: 32432411.
      View in: PubMed   Mentions:
    6. Peri-tumor administration of controlled release anti-CTLA-4 synergizes with systemic anti-PD-1 to induce systemic antitumor immunity while sparing autoimmune toxicity. Cancer Immunol Immunother. 2020 Sep; 69(9):1737-1749. Harui A, McLachlan SM, Rapoport B, Zarembinski TI, Roth MD. PMID: 32333082.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    7. Impact of marijuana smoking on lung function in older persons. Eur Respir J. 2020 02; 55(2). Tashkin DP, Roth MD. PMID: 32079670.
      View in: PubMed   Mentions:    Fields:    
    8. Using Transitional Changes on High-Resolution Computed Tomography to Monitor the Impact of Cyclophosphamide or Mycophenolate Mofetil on Systemic Sclerosis-Related Interstitial Lung Disease. Arthritis Rheumatol. 2020 02; 72(2):316-325. Kim GHJ, Tashkin DP, Lo P, Brown MS, Volkmann ER, Gjertson DW, Khanna D, Elashoff RM, Tseng CH, Roth MD, Goldin JG. PMID: 31430058.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    9. Progression of Interstitial Lung Disease in Systemic Sclerosis: The Importance of Pneumoproteins Krebs von den Lungen 6 and CCL18. Arthritis Rheumatol. 2019 12; 71(12):2059-2067. Volkmann ER, Tashkin DP, Kuwana M, Li N, Roth MD, Charles J, Hant FN, Bogatkevich GS, Akter T, Kim G, Goldin J, Khanna D, Clements PJ, Furst DE, Elashoff RM, Silver RM, Assassi S. PMID: 31233287.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    10. Pulmonary effects of inhaled cannabis smoke. Am J Drug Alcohol Abuse. 2019; 45(6):596-609. Tashkin DP, Roth MD. PMID: 31298945.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    11. Cyclophosphamide for Systemic Sclerosis-related Interstitial Lung Disease: A Comparison of Scleroderma Lung Study I and II. J Rheumatol. 2019 10; 46(10):1316-1325. Volkmann ER, Tashkin DP, Sim M, Li N, Khanna D, Roth MD, Clements PJ, Hoffmann-Vold AM, Furst DE, Kim G, Goldin J, Elashoff RM. PMID: 30770517.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    12. Minimal Clinically Important Differences for the Modified Rodnan Skin Score: Results from the Scleroderma Lung Studies (SLS-I and SLS-II). Arthritis Res Ther. 2019 01 16; 21(1):23. Khanna D, Clements PJ, Volkmann ER, Wilhalme H, Tseng CH, Furst DE, Roth MD, Distler O, Tashkin DP. PMID: 30651141.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    13. Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts. Ann Rheum Dis. 2019 01; 78(1):122-130. Volkmann ER, Tashkin DP, Sim M, Li N, Goldmuntz E, Keyes-Elstein L, Pinckney A, Furst DE, Clements PJ, Khanna D, Steen V, Schraufnagel DE, Arami S, Hsu V, Roth MD, Elashoff RM, Sullivan KM, SLS I and SLS II study groups . PMID: 30409830.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    14. Efficacy of Mycophenolate Mofetil and Oral Cyclophosphamide on Skin Thickness: Post Hoc Analyses From Two Randomized Placebo-Controlled Trials. Arthritis Care Res (Hoboken). 2018 03; 70(3):439-444. Namas R, Tashkin DP, Furst DE, Wilhalme H, Tseng CH, Roth MD, Kafaja S, Volkmann E, Clements PJ, Khanna D, Participants in the Scleroderma Lung Study I and members of the Scleroderma Lung Study II Research G . PMID: 28544580.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    15. A Prospective Study of Humoral and Cellular Immune Responses to Hepatitis B Vaccination in Habitual Marijuana Smokers. J Neuroimmune Pharmacol. 2018 06; 13(2):219-229. Kiertscher SM, Gangalum PR, Ibrahim G, Tashkin DP, Roth MD. PMID: 29340893.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    16. Reliability and minimal clinically important differences of forced vital capacity: Results from the Scleroderma Lung Studies (SLS-I and SLS-II). Am J Respir Crit Care Med. 2018 03 01; 197(5):644-652. Kafaja S, Clements PJ, Wilhalme H, Tseng CH, Furst DE, Kim GH, Goldin J, Volkmann ER, Roth MD, Tashkin DP, Khanna D. PMID: 29099620.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    17. Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis-Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II. Arthritis Rheumatol. 2017 07; 69(7):1451-1460. Volkmann ER, Tashkin DP, Li N, Roth MD, Khanna D, Hoffmann-Vold AM, Kim G, Goldin J, Clements PJ, Furst DE, Elashoff RM. PMID: 28376288.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    18. Regulation of Cell Surface CB2 Receptor during Human B Cell Activation and Differentiation. J Neuroimmune Pharmacol. 2017 09; 12(3):544-554. Castaneda JT, Harui A, Roth MD. PMID: 28364261.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    19. Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease. Arthritis Res Ther. 2016 12 30; 18(1):305. Volkmann ER, Tashkin DP, Roth MD, Clements PJ, Khanna D, Furst DE, Mayes M, Charles J, Tseng CH, Elashoff RM, Assassi S. PMID: 28038680.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    20. Improved Cough and Cough-Specific Quality of Life in Patients Treated for Scleroderma-Related Interstitial Lung Disease: Results of Scleroderma Lung Study II. Chest. 2017 Apr; 151(4):813-820. Tashkin DP, Volkmann ER, Tseng CH, Roth MD, Khanna D, Furst DE, Clements PJ, Theodore A, Kafaja S, Kim GH, Goldin J, Ariolla E, Elashoff RM. PMID: 28012804.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    21. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial. Lancet Respir Med. 2016 09; 4(9):708-719. Tashkin DP, Roth MD, Clements PJ, Furst DE, Khanna D, Kleerup EC, Goldin J, Arriola E, Volkmann ER, Kafaja S, Silver R, Steen V, Strange C, Wise R, Wigley F, Mayes M, Riley DJ, Hussain S, Assassi S, Hsu VM, Patel B, Phillips K, Martinez F, Golden J, Connolly MK, Varga J, Dematte J, Hinchcliff ME, Fischer A, Swigris J, Meehan R, Theodore A, Simms R, Volkov S, Schraufnagel DE, Scholand MB, Frech T, Molitor JA, Highland K, Read CA, Fritzler MJ, Kim GHJ, Tseng CH, Elashoff RM, Sclerodema Lung Study II Investigators . PMID: 27469583.
      View in: PubMed   Mentions: 173     Fields:    Translation:Humans
    22. Transitions to different patterns of interstitial lung disease in scleroderma with and without treatment. Ann Rheum Dis. 2016 Jul; 75(7):1367-71. Kim HJ, Tashkin DP, Gjertson DW, Brown MS, Kleerup E, Chong S, Belperio JA, Roth MD, Abtin F, Elashoff R, Tseng CH, Khanna D, Goldin JG. PMID: 26757749.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    23. Predictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis-associated interstitial lung disease trials. Arthritis Res Ther. 2015 Dec 23; 17:372. Khanna D, Nagaraja V, Tseng CH, Abtin F, Suh R, Kim G, Wells A, Furst DE, Clements PJ, Roth MD, Tashkin DP, Goldin J. PMID: 26704522.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    24. Human tumor infiltrating lymphocytes cooperatively regulate prostate tumor growth in a humanized mouse model. J Immunother Cancer. 2015; 3:12. Roth MD, Harui A. PMID: 25901284.
      View in: PubMed   Mentions: 16     Fields:    
    25. Exposure to Δ9-Tetrahydrocannabinol Impairs the Differentiation of Human Monocyte-derived Dendritic Cells and their Capacity for T cell Activation. J Neuroimmune Pharmacol. 2015 Jun; 10(2):333-43. Roth MD, Castaneda JT, Kiertscher SM. PMID: 25614186.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    26. Relationship between quantitative radiographic assessments of interstitial lung disease and physiological and clinical features of systemic sclerosis. Ann Rheum Dis. 2016 Feb; 75(2):374-81. Tashkin DP, Volkmann ER, Tseng CH, Kim HJ, Goldin J, Clements P, Furst D, Khanna D, Kleerup E, Roth MD, Elashoff R. PMID: 25452309.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    27. Pleural effusions, eosinophilia and a positive interferon-γ release assay. Respiration. 2013; 86(6):508-11. Howard-Anderson J, Canan T, Roth MD, Ha E. PMID: 24217390.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsPHPublic Health
    28. Increased matrix metalloproteinase (MMPs) levels do not predict disease severity or progression in emphysema. PLoS One. 2013; 8(2):e56352. D'Armiento JM, Goldklang MP, Hardigan AA, Geraghty P, Roth MD, Connett JE, Wise RA, Sciurba FC, Scharf SM, Thankachen J, Islam M, Ghio AJ, Foronjy RF. PMID: 23441181.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    29. Differential expression of intracellular and extracellular CB(2) cannabinoid receptor protein by human peripheral blood leukocytes. J Neuroimmune Pharmacol. 2013 Mar; 8(1):323-32. Castaneda JT, Harui A, Kiertscher SM, Roth JD, Roth MD. PMID: 23299999.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    30. Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: analysis of the Scleroderma Lung Study Placebo Group. Arthritis Rheum. 2011 Oct; 63(10):3078-85. Khanna D, Tseng CH, Farmani N, Steen V, Furst DE, Clements PJ, Roth MD, Goldin J, Elashoff R, Seibold JR, Saggar R, Tashkin DP. PMID: 21618205.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    31. Predicting treatment outcomes and responder subsets in scleroderma-related interstitial lung disease. Arthritis Rheum. 2011 Sep; 63(9):2797-808. Roth MD, Tseng CH, Clements PJ, Furst DE, Tashkin DP, Goldin JG, Khanna D, Kleerup EC, Li N, Elashoff D, Elashoff RM, Scleroderma Lung Study Research Group . PMID: 21547897.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    32. Lung cancer chemoprevention with celecoxib in former smokers. Cancer Prev Res (Phila). 2011 Jul; 4(7):984-93. Mao JT, Roth MD, Fishbein MC, Aberle DR, Zhang ZF, Rao JY, Tashkin DP, Goodglick L, Holmes EC, Cameron RB, Dubinett SM, Elashoff R, Szabo E, Elashoff D. PMID: 21733822.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCTClinical Trials
    33. Adverse events during the Scleroderma Lung Study. Am J Med. 2011 May; 124(5):459-67. Furst DE, Tseng CH, Clements PJ, Strange C, Tashkin DP, Roth MD, Khanna D, Li N, Elashoff R, Schraufnagel DE, Scleroderma Lung Study . PMID: 21531236.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    34. Course of dermal ulcers and musculoskeletal involvement in systemic sclerosis patients in the scleroderma lung study. Arthritis Care Res (Hoboken). 2010 Dec; 62(12):1772-8. Au K, Mayes MD, Maranian P, Clements PJ, Khanna D, Steen VD, Tashkin D, Roth MD, Elashoff R, Furst DE. PMID: 20740615.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    35. Reconstitution of huPBL-NSG mice with donor-matched dendritic cells enables antigen-specific T-cell activation. J Neuroimmune Pharmacol. 2011 Mar; 6(1):148-57. Harui A, Kiertscher SM, Roth MD. PMID: 20532647.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    36. Redirecting lentiviral vectors pseudotyped with Sindbis virus-derived envelope proteins to DC-SIGN by modification of N-linked glycans of envelope proteins. J Virol. 2010 Jul; 84(14):6923-34. Morizono K, Ku A, Xie Y, Harui A, Kung SK, Roth MD, Lee B, Chen IS. PMID: 20484510.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    37. Eosinophil and T cell markers predict functional decline in COPD patients. Respir Res. 2009 Nov 19; 10:113. D'Armiento JM, Scharf SM, Roth MD, Connett JE, Ghio A, Sternberg D, Goldin JG, Louis TA, Mao JT, O'Connor GT, Ramsdell JW, Ries AL, Schluger NW, Sciurba FC, Skeans MA, Voelker H, Walter RE, Wendt CH, Weinmann GG, Wise RA, Foronjy RF. PMID: 19925666.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    38. Treatment of scleroderma-interstitial lung disease with cyclophosphamide is associated with less progressive fibrosis on serial thoracic high-resolution CT scan than placebo: findings from the scleroderma lung study. Chest. 2009 Nov; 136(5):1333-1340. Goldin J, Elashoff R, Kim HJ, Yan X, Lynch D, Strollo D, Roth MD, Clements P, Furst DE, Khanna D, Vasunilashorn S, Li G, Tashkin DP. PMID: 19892673.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    39. Recruitment strategies for a lung cancer chemoprevention trial involving ex-smokers. Contemp Clin Trials. 2009 Sep; 30(5):464-72. Kye SH, Tashkin DP, Roth MD, Adams B, Nie WX, Mao JT. PMID: 19508900.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    40. Recreational drug use and risk of Kaposi's sarcoma in HIV- and HHV-8-coinfected homosexual men. AIDS Res Hum Retroviruses. 2009 Feb; 25(2):149-56. Chao C, Jacobson LP, Jenkins FJ, Tashkin D, Martínez-Maza O, Roth MD, Ng L, Margolick JB, Chmiel JS, Zhang ZF, Detels R. PMID: 19108691.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    41. Recreational amphetamine use and risk of HIV-related non-Hodgkin lymphoma. Cancer Causes Control. 2009 Jul; 20(5):509-16. Chao C, Jacobson LP, Tashkin D, Martínez-Maza O, Roth MD, Margolick JB, Chmiel JS, Holloway MN, Zhang ZF, Detels R. PMID: 19011979.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    42. High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease. Chest. 2008 Aug; 134(2):358-367. Goldin JG, Lynch DA, Strollo DC, Suh RD, Schraufnagel DE, Clements PJ, Elashoff RM, Furst DE, Vasunilashorn S, McNitt-Gray MF, Brown MS, Roth MD, Tashkin DP, Scleroderma Lung Study Research Group . PMID: 18641099.
      View in: PubMed   Mentions: 63     Fields:    Translation:Humans
    43. Clarifying CB2 receptor-dependent and independent effects of THC on human lung epithelial cells. Toxicol Appl Pharmacol. 2008 Sep 15; 231(3):282-90. Sarafian T, Montes C, Harui A, Beedanagari SR, Kiertscher S, Stripecke R, Hossepian D, Kitchen C, Kern R, Belperio J, Roth MD. PMID: 18556036.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    44. Recreational drug use and T lymphocyte subpopulations in HIV-uninfected and HIV-infected men. Drug Alcohol Depend. 2008 Apr 01; 94(1-3):165-71. Chao C, Jacobson LP, Tashkin D, Martínez-Maza O, Roth MD, Margolick JB, Chmiel JS, Rinaldo C, Zhang ZF, Detels R. PMID: 18180115.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    45. Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease. Am J Respir Crit Care Med. 2008 Jan 01; 177(1):91-8. Strange C, Bolster MB, Roth MD, Silver RM, Theodore A, Goldin J, Clements P, Chung J, Elashoff RM, Suh R, Smith EA, Furst DE, Tashkin DP, Scleroderma Lung Study Research Group . PMID: 17901414.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    46. Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease. Am J Respir Crit Care Med. 2007 Nov 15; 176(10):1026-34. Tashkin DP, Elashoff R, Clements PJ, Roth MD, Furst DE, Silver RM, Goldin J, Arriola E, Strange C, Bolster MB, Seibold JR, Riley DJ, Hsu VM, Varga J, Schraufnagel D, Theodore A, Simms R, Wise R, Wigley F, White B, Steen V, Read C, Mayes M, Parsley E, Mubarak K, Connolly MK, Golden J, Olman M, Fessler B, Rothfield N, Metersky M, Khanna D, Li N, Li G, Scleroderma Lung Study Research Group . PMID: 17717203.
      View in: PubMed   Mentions: 112     Fields:    Translation:Humans
    47. Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis. Ann Rheum Dis. 2007 Dec; 66(12):1641-7. Clements PJ, Roth MD, Elashoff R, Tashkin DP, Goldin J, Silver RM, Sterz M, Seibold JR, Schraufnagel D, Simms RW, Bolster M, Wise RA, Steen V, Mayes MD, Connelly K, Metersky M, Furst DE, Scleroderma Lung Study Group . PMID: 17485423.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    48. Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study. Arthritis Rheum. 2007 May; 56(5):1676-84. Khanna D, Yan X, Tashkin DP, Furst DE, Elashoff R, Roth MD, Silver R, Strange C, Bolster M, Seibold JR, Riley DJ, Hsu VM, Varga J, Schraufnagel DE, Theodore A, Simms R, Wise R, Wigley F, White B, Steen V, Read C, Mayes M, Parsley E, Mubarak K, Connolly MK, Golden J, Olman M, Fessler B, Rothfield N, Metersky M, Clements PJ, Scleroderma Lung Study Group . PMID: 17469162.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    49. Feasibility of retinoids for the treatment of emphysema study. Chest. 2006 Nov; 130(5):1334-45. Roth MD, Connett JE, D'Armiento JM, Foronjy RF, Friedman PJ, Goldin JG, Louis TA, Mao JT, Muindi JR, O'Connor GT, Ramsdell JW, Ries AL, Scharf SM, Schluger NW, Sciurba FC, Skeans MA, Walter RE, Wendt CH, Wise RA, FORTE Study Investigators . PMID: 17099008.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    50. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med. 2006 Jun 22; 354(25):2655-66. Tashkin DP, Elashoff R, Clements PJ, Goldin J, Roth MD, Furst DE, Arriola E, Silver R, Strange C, Bolster M, Seibold JR, Riley DJ, Hsu VM, Varga J, Schraufnagel DE, Theodore A, Simms R, Wise R, Wigley F, White B, Steen V, Read C, Mayes M, Parsley E, Mubarak K, Connolly MK, Golden J, Olman M, Fessler B, Rothfield N, Metersky M, Scleroderma Lung Study Research Group . PMID: 16790698.
      View in: PubMed   Mentions: 361     Fields:    Translation:Humans
    51. Centrifugation enhances integrin-mediated transduction of dendritic cells by conventional and RGD-modified adenoviral vectors. J Immunol Methods. 2006 May 30; 312(1-2):94-104. Harui A, Roth MD, Sanghvi M, Vira D, Mizuguchi H, Basak SK. PMID: 16626731.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    52. Adenoviral-encoded antigens are presented efficiently by a subset of dendritic cells expressing high levels of alpha(v)beta3 integrins. J Leukoc Biol. 2006 Jun; 79(6):1271-8. Harui A, Roth MD, Vira D, Sanghvi M, Mizuguchi H, Basak SK. PMID: 16574766.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    53. Inhaled marijuana smoke disrupts mitochondrial energetics in pulmonary epithelial cells in vivo. . 2006 Jun; 290(6):L1202-9. Sarafian TA, Habib N, Oldham M, Seeram N, Lee RP, Lin L, Tashkin DP, Roth MD. PMID: 16414979.
      View in: PubMed   Mentions:
    54. Celecoxib decreases Ki-67 proliferative index in active smokers. Clin Cancer Res. 2006 Jan 01; 12(1):314-20. Mao JT, Fishbein MC, Adams B, Roth MD, Goodglick L, Hong L, Burdick M, Strieter ER, Holmes C, Tashkin DP, Dubinett SM. PMID: 16397057.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    55. Cocaine and sigma-1 receptors modulate HIV infection, chemokine receptors, and the HPA axis in the huPBL-SCID model. J Leukoc Biol. 2005 Dec; 78(6):1198-203. Roth MD, Whittaker KM, Choi R, Tashkin DP, Baldwin GC. PMID: 16204638.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansAnimalsCells
    56. Tetrahydrocannabinol suppresses immune function and enhances HIV replication in the huPBL-SCID mouse. Life Sci. 2005 Aug 19; 77(14):1711-22. Roth MD, Tashkin DP, Whittaker KM, Choi R, Baldwin GC. PMID: 15964028.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimalsCells
    57. Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment. Clin Cancer Res. 2005 Aug 01; 11(15):5515-25. Liau LM, Prins RM, Kiertscher SM, Odesa SK, Kremen TJ, Giovannone AJ, Lin JW, Chute DJ, Mischel PS, Cloughesy TF, Roth MD. PMID: 16061868.
      View in: PubMed   Mentions: 216     Fields:    Translation:HumansCellsCTClinical Trials
    58. Gene expression changes in human small airway epithelial cells exposed to Delta9-tetrahydrocannabinol. Toxicol Lett. 2005 Aug 14; 158(2):95-107. Sarafian T, Habib N, Mao JT, Tsu IH, Yamamoto ML, Hsu E, Tashkin DP, Roth MD. PMID: 16039398.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    59. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study. Arthritis Rheum. 2005 Feb; 52(2):592-600. Khanna D, Clements PJ, Furst DE, Chon Y, Elashoff R, Roth MD, Sterz MG, Chung J, FitzGerald JD, Seibold JR, Varga J, Theodore A, Wigley FM, Silver RM, Steen VD, Mayes MD, Connolly MK, Fessler BJ, Rothfield NF, Mubarak K, Molitor J, Tashkin DP, Scleroderma Lung Study Group . PMID: 15692967.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCTClinical Trials
    60. Modulation of pulmonary leukotriene B4 production by cyclooxygenase-2 inhibitors and lipopolysaccharide. Clin Cancer Res. 2004 Oct 15; 10(20):6872-8. Mao JT, Tsu IH, Dubinett SM, Adams B, Sarafian T, Baratelli F, Roth MD, Serio KJ. PMID: 15501964.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCellsCTClinical Trials
    61. Regional differences in bronchoalveolar lavage and thoracic high-resolution computed tomography results in dyspneic patients with systemic sclerosis. Arthritis Rheum. 2004 Jun; 50(6):1909-17. Clements PJ, Goldin JG, Kleerup EC, Furst DE, Elashoff RM, Tashkin DP, Roth MD. PMID: 15188367.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    62. Cocaine modulates cytokine and enhances tumor growth through sigma receptors. J Neuroimmunol. 2004 Feb; 147(1-2):95-8. Gardner B, Zhu LX, Roth MD, Tashkin DP, Dubinett SM, Sharma S. PMID: 14741436.
      View in: PubMed   Mentions: 16     Fields:    Translation:AnimalsCells
    63. Mechanisms for impaired effector function in alveolar macrophages from marijuana and cocaine smokers. J Neuroimmunol. 2004 Feb; 147(1-2):82-6. Roth MD, Whittaker K, Salehi K, Tashkin DP, Baldwin GC. PMID: 14741433.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    64. Modifying adenoviral vectors for use as gene-based cancer vaccines. Viral Immunol. 2004; 17(2):182-96. Basak SK, Kiertscher SM, Harui A, Roth MD. PMID: 15279698.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    65. Celecoxib modulates the capacity for prostaglandin E2 and interleukin-10 production in alveolar macrophages from active smokers. Clin Cancer Res. 2003 Dec 01; 9(16 Pt 1):5835-41. Mao JT, Roth MD, Serio KJ, Baratelli F, Zhu L, Holmes EC, Strieter RM, Dubinett SM. PMID: 14676104.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    66. All-trans retinoic acid modulates the balance of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in patients with emphysema. Chest. 2003 Nov; 124(5):1724-32. Mao JT, Tashkin DP, Belloni PN, Baileyhealy I, Baratelli F, Roth MD. PMID: 14605041.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCellsCTClinical Trials
    67. Granulocyte/macrophage-colony stimulating factor and interleukin-4 expand and activate type-1 dendritic cells (DC1) when administered in vivo to cancer patients. Int J Cancer. 2003 Nov 01; 107(2):256-61. Kiertscher SM, Gitlitz BJ, Figlin RA, Roth MD. PMID: 12949803.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCellsCTClinical Trials
    68. Phase I trial of granulocyte macrophage-colony stimulating factor and interleukin-4 as a combined immunotherapy for patients with cancer. J Immunother. 2003 Mar-Apr; 26(2):171-8. Gitlitz BJ, Figlin RA, Kiertscher SM, Moldawer N, Rosen F, Roth MD. PMID: 12616109.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    69. Impairment of antimicrobial activity and nitric oxide production in alveolar macrophages from smokers of marijuana and cocaine. J Infect Dis. 2003 Feb 15; 187(4):700-4. Shay AH, Choi R, Whittaker K, Salehi K, Kitchen CM, Tashkin DP, Roth MD, Baldwin GC. PMID: 12599091.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    70. Effects of delta-9-tetrahydrocannabinol on human immune function and host defense. Chem Phys Lipids. 2002 Dec 31; 121(1-2):229-39. Roth MD, Baldwin GC, Tashkin DP. PMID: 12505703.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    71. Delta 9-Tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells. J Neuroimmunol. 2002 Dec; 133(1-2):124-31. Yuan M, Kiertscher SM, Cheng Q, Zoumalan R, Tashkin DP, Roth MD. PMID: 12446015.
      View in: PubMed   Mentions: 70     Fields:    Translation:HumansCells
    72. Respiratory and immunologic consequences of marijuana smoking. J Clin Pharmacol. 2002 11; 42(S1):71S-81S. Tashkin DP, Baldwin GC, Sarafian T, Dubinett S, Roth MD. PMID: 12412839.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCells
    73. Delta 9-tetrahydrocannabinol disrupts mitochondrial function and cell energetics. . 2003 Feb; 284(2):L298-306. Sarafian TA, Kouyoumjian S, Khoshaghideh F, Tashkin DP, Roth MD. PMID: 12533310.
      View in: PubMed   Mentions:
    74. Helper-dependent adenoviral vectors efficiently express transgenes in human dendritic cells but still stimulate antiviral immune responses. J Immunol. 2002 Oct 15; 169(8):4651-6. Roth MD, Cheng Q, Harui A, Basak SK, Mitani K, Low TA, Kiertscher SM. PMID: 12370405.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    75. Synergistic cytotoxicity of Delta(9)-tetrahydrocannabinol and butylated hydroxyanisole. Toxicol Lett. 2002 Jul 21; 133(2-3):171-9. Sarafian TA, Kouyoumjian S, Tashkin D, Roth MD. PMID: 12119125.
      View in: PubMed   Mentions: 11     Fields:    Translation:AnimalsCells
    76. Altered cannabinoid receptor mRNA expression in peripheral blood mononuclear cells from marijuana smokers. J Neuroimmunol. 2002 Jun; 127(1-2):169-76. Nong L, Newton C, Cheng Q, Friedman H, Roth MD, Klein TW. PMID: 12044989.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    77. Increased dendritic cell number and function following continuous in vivo infusion of granulocyte macrophage-colony-stimulating factor and interleukin-4. Blood. 2002 Apr 15; 99(8):2869-79. Basak SK, Harui A, Stolina M, Sharma S, Mitani K, Dubinett SM, Roth MD. PMID: 11929777.
      View in: PubMed   Mentions: 16     Fields:    Translation:AnimalsCells
    78. Evidence of chronic damage to the pulmonary microcirculation in habitual users of alkaloidal ("crack") cocaine. Chest. 2002 Apr; 121(4):1231-8. Baldwin GC, Choi R, Roth MD, Shay AH, Kleerup EC, Simmons MS, Tashkin DP. PMID: 11948058.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    79. A pilot study of all-trans-retinoic acid for the treatment of human emphysema. Am J Respir Crit Care Med. 2002 Mar 01; 165(5):718-23. Mao JT, Goldin JG, Dermand J, Ibrahim G, Brown MS, Emerick A, McNitt-Gray MF, Gjertson DW, Estrada F, Tashkin DP, Roth MD. PMID: 11874821.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCTClinical Trials
    80. Cocaine enhances human immunodeficiency virus replication in a model of severe combined immunodeficient mice implanted with human peripheral blood leukocytes. J Infect Dis. 2002 Mar 01; 185(5):701-5. Roth MD, Tashkin DP, Choi R, Jamieson BD, Zack JA, Baldwin GC. PMID: 11865430.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansAnimalsCells
    81. Induction and regulation of the carcinogen-metabolizing enzyme CYP1A1 by marijuana smoke and delta (9)-tetrahydrocannabinol. Am J Respir Cell Mol Biol. 2001 Mar; 24(3):339-44. Roth MD, Marques-Magallanes JA, Yuan M, Sun W, Tashkin DP, Hankinson O. PMID: 11245634.
      View in: PubMed   Mentions: 18     Fields:    Translation:AnimalsCells
    82. Granulocyte macrophage colony-stimulating factor and interleukin 4 enhance the number and antigen-presenting activity of circulating CD14+ and CD83+ cells in cancer patients. Cancer Res. 2000 Apr 01; 60(7):1934-41. Roth MD, Gitlitz BJ, Kiertscher SM, Park AN, Mendenhall M, Moldawer N, Figlin RA. PMID: 10766183.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCellsCTClinical Trials
    Michael's Networks
    Concepts (401)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (31)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version v3.1.0-865-g7865d7b0 on PROFILES-PWEB01.

    Copyright © The Regents of the University of California